Efficacy and tolerability of low-frequency deep brain stimulation during daytime only in Parkinson’s disease: a pilot study
Objective: To compare the efficacy and tolerability of low-frequency stimulation (LFS) during daytime only to LFS applied 24 hours a day, in PD patients bilaterally…Effects of subthalamic and nigral stimulation on gait kinematics in Parkinson’s disease
Objective: In this work, we aimed to characterize the differential effect of subthalamic nucleus (STN) or substantia nigra pars reticulata (SNr) stimulation on kinematic gait…Interleaved Stimulation for Freezing of Gait in Advanced Parkinson’s Disease: A Pilot Study
Objective: To assess the effect of Interleaved Stimulation (ILS) in patients receiving subthalamic nucleus-Deep Brain Stimulation (STN-DBS), with Freezing of gait (FOG) unresponsive to medication and conventional…Low Incidence of Extrapyramidal Symptoms in Subjects with Tardive Dyskinesia Receiving Long-Term Valbenazine (NBI-98854) Treatment
Objective: To assess the emergence of extrapyramidal symptoms (EPS) such as akathisia and parkinsonism in adults with a diagnosis of schizophrenia/schizoaffective disorder or mood disorder…Dopamine Agonists and Postural Disorders in Parkinson’s disease
Objective: To evaluate the relationship between treatment with DA and the development of postural disorders (CC, PS and AC) in patients with PD. Background: Stood…Exploiting sequence data of genes involved in synthesis of plant derived enzyme inhibitors of Acetylcholinesterase that involve in antineurodegenerative acitivity.
Objective: Sequence analysis of genes involved in acetylcholinesterase inhibitors biosynthesis from various plant species Background: The neurodegenerative disease like Alzheimer’s disease and Parkinson’s disease involve…Сase of myotonic dystrophy
Objective: Myotonic dystrophy (dystrophia myotonica, DM) is the most frequently inherited neuromuscular disease of adult life. Background: Classical DM (DM1) has been identified as an…Salivary biomarkers for Huntington’s disease (HD)
Objective: The objective of the current study was to assess the potential for saliva to serve as a biospecimen for accessible biomarkers for Huntington’s disease…Inhibiting sphingosine-1-phosphate lyase as a possible therapy in Huntington’s disease
Objective: To advance our understanding of the process by which the mutant huntingtin (mHTT) protein contributes to neurodegeneration and translate that knowledge to potentially effective disease…Social hindrances for diagnosing Huntington’s disease
Objective: The need to differentiate the malingering from real complains Careful history can give a strong clue for the diagnosis Criminals can have diseases also…
- 1
- 2
- 3
- …
- 155
- Next Page »